We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Clearwater Paper
CLW
$271M
| $281K | ﹤0.01% |
5,792
-37,347
| -87% | -$1.56M |
|
927
Kinder Morgan
KMI
$73.1B
| $281K | ﹤0.01% |
+15,727
| New | +$257K |
|
|
AAWW
928
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $280K | ﹤0.01% |
+6,631
| New | +$248K |
|
929
Rio Tinto
RIO
$148B
| $278K | ﹤0.01% |
+9,823
| New | +$262K |
|
930
AES
AES
$10.6B
| $277K | ﹤0.01% |
+23,488
| New | +$234K |
|
|
STR
931
DELISTED
QUESTAR CORP
STR
| $274K | ﹤0.01% |
+11,055
| New | +$255K |
|
932
Deluxe
DLX
$1.19B
| $273K | ﹤0.01% |
+4,374
| New | +$244K |
|
933
Nexstar Media Group
NXST
$5.6B
| $271K | ﹤0.01% |
+6,113
| New | +$277K |
|
934
Insulet
PODD
$11.3B
| $271K | ﹤0.01% |
+8,173
| New | +$257K |
|
935
Atlassian
TEAM
$22B
| $265K | ﹤0.01% |
+10,545
| New | +$247K |
|
|
P
936
Everpure Inc
P
$24.8B
| $261K | ﹤0.01% |
+19,083
| New | +$253K |
|
|
INFI
937
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $261K | ﹤0.01% |
+49,589
| New | +$303K |
|
938
MDU Resources
MDU
$4.44B
| $260K | ﹤0.01% |
+35,204
| New | +$237K |
|
|
MTOR
939
DELISTED
MERITOR, Inc.
MTOR
| $260K | ﹤0.01% |
+32,240
| New | +$235K |
|
940
Applied Optoelectronics
AAOI
$8.04B
| $257K | ﹤0.01% |
+17,256
| New | +$274K |
|
|
TE
941
DELISTED
TECO ENERGY INC
TE
| $254K | ﹤0.01% |
9,234
-10,672
| -54% | -$291K |
|
|
SPLK
942
DELISTED
Splunk Inc
SPLK
| $253K | ﹤0.01% |
+5,167
| New | +$233K |
|
|
CPPL
943
DELISTED
Columbia Pipeline Partners LP
CPPL
| $251K | ﹤0.01% |
+17,200
| New | +$264K |
|
944
Revvity
RVTY
$12.3B
| $250K | ﹤0.01% |
5,060
-15,029
| -75% | -$718K |
|
945
Travere Therapeutics
TVTX
$5.33B
| $249K | ﹤0.01% |
+18,242
| New | +$277K |
|
|
RDS.B
946
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $247K | ﹤0.01% |
+5,026
| New | +$226K |
|
947
CRH
CRH
$66.7B
| $241K | ﹤0.01% |
+8,564
| New | +$227K |
|
|
VVC
948
DELISTED
Vectren Corporation
VVC
| $238K | ﹤0.01% |
+4,715
| New | +$213K |
|
|
AMSG
949
DELISTED
Amsurg Corp
AMSG
| $238K | ﹤0.01% |
3,192
-208,007
| -98% | -$14.6M |
|
|
MZTI
950
The Marzetti Company
MZTI
$2.94B
| $237K | ﹤0.01% |
+2,140
| New | +$229K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.